Safeguard Scientifics, Inc (SFE) Receives Average Rating of “Hold” from Brokerages
Safeguard Scientifics, Inc (NYSE:SFE) has been assigned a consensus broker rating score of 3.00 (Hold) from the two brokers that cover the company, Zacks Investment Research reports. Two research analysts have rated the stock with a hold recommendation. Safeguard Scientifics’ rating score has declined by 28.8% from three months ago as a result of a number of analysts’ ratings changes.
Analysts have set a 1 year consensus price objective of $15.13 for the company and are expecting that the company will post ($0.94) earnings per share for the current quarter, according to Zacks. Zacks has also given Safeguard Scientifics an industry rank of 169 out of 257 based on the ratings given to its competitors.
Several equities analysts recently commented on SFE shares. Zacks Investment Research lowered shares of Safeguard Scientifics from a “buy” rating to a “hold” rating in a report on Wednesday, September 26th. ValuEngine lowered shares of Safeguard Scientifics from a “hold” rating to a “sell” rating in a report on Monday, July 30th. Finally, First Analysis lowered shares of Safeguard Scientifics from an “overweight” rating to an “equal weight” rating and reduced their target price for the company from $18.00 to $17.00 in a report on Thursday, July 26th.
Shares of NYSE:SFE opened at $8.33 on Wednesday. The firm has a market capitalization of $175.71 million, a PE ratio of -1.92 and a beta of 1.18. Safeguard Scientifics has a one year low of $8.24 and a one year high of $13.95. The company has a debt-to-equity ratio of 0.76, a quick ratio of 2.58 and a current ratio of 2.58.
Safeguard Scientifics (NYSE:SFE) last issued its quarterly earnings results on Thursday, October 25th. The asset manager reported $1.56 EPS for the quarter, missing the Zacks’ consensus estimate of $1.61 by ($0.05). Research analysts expect that Safeguard Scientifics will post -0.89 EPS for the current fiscal year.
About Safeguard Scientifics
Safeguard Scientifics, Inc no longer investing. It is a private equity and venture capital firm specializing in expansion financings, growth capital, management buyouts, recapitalizations, industry consolidations, corporate spinouts, growth stage, and early stage financings. It initially invests in a Series A-C round and opportunistically in a seed round.
Featured Article: How can you know how many shares are floating?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Safeguard Scientifics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Safeguard Scientifics and related companies with MarketBeat.com's FREE daily email newsletter.